TGFB1 and breast carcinoma: At 24 hours of TGF-β antibody treatment, breast cancer cell death in co-culture with Hs27a was induced compared to untreated cells (10.9 ± 3.6% vs 4.06 ± 0.8% P < 0.01) (Figure 6C).